Regentis Biomaterials Ltd. Other Noncash Income (Expense)
Regentis Biomaterials Ltd. (RGNT) reported Other Noncash Income (Expense) of -$4.94 million for the 12-month period ending 2025-12-31, per its 20-F/A filed 2026-02-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-02-27
| Period end | Other Noncash Income (Expense) 12 month |
|---|---|
| 2025-12-31 | -$4.94M 20-F/A · filed 2026-02-27 |
| 2024-12-31 | $3.48M 20-F/A · filed 2026-02-27 |
| 2023-12-31 | -$2.02M 20-F/A · filed 2026-02-27 |